Berry
Develops and manufactures patient-specific cranial orthosis helmets (BabyBand) for infants using 3D printing and 3D data analysis, achieving rapid customization and clinical scale.
- CEO / Founder
- Yuji Nakano
- Team Size
- 51-200
- Stage
- Growth Stage
- Total Funding
- $30M
Technology & Products
Key Products
BabyBand (cranial orthosis helmet)
Technological Advantage
Proprietary digital workflow integrating 3D scanning, data analysis, and vat photopolymerization printing enables fully customized, regulatory-approved (Class II) medical devices at half the cost and one-week lead time. The clinical network effect, with adoption in 260+ institutions, creates a defensible distribution moat in the Japanese market.
Differentiation
Value Proposition
Reduces production cost by 50% and lead time to 1 week for custom cranial orthoses versus traditional methods, enabling broader access to treatment across Japan.
How They Differentiate
Claims the largest number of clinical adoption sites in Japan for cranial orthosis, with a fully in-house digital manufacturing model that reduces cost and lead time significantly versus traditional orthotic labs or competing helmet providers.
Market & Competition
Target Customers
Hospitals, clinics, and medical institutions treating infant skull deformities (plagiocephaly, brachycephaly).
Industry Verticals
Medical Devices; Healthcare
Growth & Milestones
Growth Metrics
Adopted by over 260 medical institutions across 41 of Japan's 47 prefectures since July 2022; employee count 77; raised over ¥3 billion.
Major Milestones
July 2022: Market introduction of BabyBand; April 2026: Won Wellbeing Award at 14th Medtec Innovation Awards; Achieved adoption in 260+ medical institutions across 41 prefectures